Contemporary OB/GYN week in review: Elinzanetant, MIRA, and more

News
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Contemporary OB/GYN week in review: Elinzanetant, MIRA, and more

Contemporary OB/GYN week in review: Elinzanetant, MIRA, and more

Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, July 29 - Friday, August 02, 2024), and click each link to read and watch anything you may have missed.

1.) Bayer submits NDA for elinzanetant to treat vasomotor symptoms

Bayer has submitted a New Drug Application for elinzanetant, following positive results from the OASIS studies, showing significant safety and efficacy in treating moderate-to-severe vasomotor symptoms in menopausal women.

Click here for the full article.

2.) First hysterectomy using miniaturized MIRA Surgical System performed

Virtual Incision Corporation has announced the successful performance of the first benign hysterectomy using their miniaturized robotic-assisted surgery device, MIRA, in a clinical trial assessing its safety and efficacy.

Click here for the full article.

3.) Surge in self-managed abortions reported post-Dobbs decision

Following the Supreme Court's Dobbs decision, rates of self-managed abortions have risen significantly, especially among marginalized communities, highlighting growing barriers to accessing legal abortion care.

Click here for the full article.

4.) Gestational carrier pregnancies: Balancing outcomes and risks

A recent study highlights the improved outcomes yet elevated risks associated with gestational carrier pregnancies compared to general pregnancies.

Click here for the full article.

5.) Preeclampsia linked to increased vascular dementia risk

A recent study found that women with preeclampsia during pregnancy face a higher risk of developing vascular dementia, but additional data was needed for other forms of dementia.

Click here for the full article.

Recent Videos
Negative pressure wound therapy reduces c-section infections and costs | Image Credit: doctors.valleyhealth.com.
Amy Valent DO, MCR, highlights new tech for prenatal diabetes management | Image Credit: linkedin.com.
Lisa Bayer, MD, MPH
Megan Wasson, DO, FACOG
Megan Cohen, MD, MPH, outlines 2024 CDC contraception guidelines | Image Credit: linkedin.com.
Wasson and Colak
Johanna Finkle, MD, weight loss specialist, OB/GYN, The University of Kansas Health System.
Navigating hormone therapy in high-risk menopause cases | Image Credit: © dhaj7-cepo.com.
Non-hormonal treatments offer relief for genitourinary syndrome of menopause | Image Credit: providers.uthscsa.edu.
Laxmi Gannu, MD, notes PPD screening gaps and adverse outcomes | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.